Lara Davis: A bench to clinic to bench to clinic story in Ewing sarcoma

Lara Davis, OHSU Knight Cancer Institute Sarcoma Program Director, shared on Twitter:

“A bench to clinic to bench to clinic story in Ewing sarcoma.
CTOS2023, TRABECTEDIN AS A 1-HOUR INFUSION IN COMBO WITH LOW DOSE IRINOTECAN.
Knowing the Ewing’s PK threshold informed study design – and when hit, EWS-FLI1 transcriptome reverses!”

Source: Lara Davis/Twitter